Pacer Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,572
| Closed | -$72K | – | 1453 |
|
2021
Q1 | $72K | Sell |
2,572
-1,664
| -39% | -$46.6K | ﹤0.01% | 1361 |
|
2020
Q4 | $110K | Buy |
4,236
+1,820
| +75% | +$47.3K | ﹤0.01% | 1352 |
|
2020
Q3 | $90K | Buy |
+2,416
| New | +$90K | ﹤0.01% | 1264 |
|
2018
Q4 | – | Sell |
-5,090
| Closed | -$226K | – | 707 |
|
2018
Q3 | $226K | Buy |
+5,090
| New | +$226K | 0.01% | 1007 |
|
2018
Q1 | – | Sell |
-1,400
| Closed | -$92K | – | 1066 |
|
2017
Q4 | $92K | Buy |
+1,400
| New | +$92K | 0.01% | 967 |
|